PFE

Investor enthusiasm hit a fever pitch following the 2024 election, but took a punch to the gut recently. Market indexes...

Pfizer (PFE) closed at $26.21 in the latest trading session, marking a -0.38% move from the prior day.

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the discount...

Pfizer's CEO said he may move manufacturing back to the US in response to Donald Trump's tariffs. Albert Bourla said...

Buying low to sell later when the stock's price is high is a time-honored investing strategy. With the benchmark S&P...

SMMT's Q4 results meet estimates. The company signs a deal with Pfizer that expands ivonescimab's development beyond the NSCLC indication.

Pfizer (PFE -0.43%) has been around for 175 years, but the company's revenue soared to its highest ever only in...

Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical...

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

On Thursday, Truist initiated coverage on BioNTech SE BNTX, a famed COVID-19 vaccine maker, in collaboration with Pfizer Inc PFE.